Revisiting Combination Antibiotic Therapy for Community-Acquired Invasive Streptococcus pneumoniae Pneumonia

Le résumé fourni par la source

1. Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38:1159-66. 2. Gardner EM, Connick E. Illness of immune reconstitution: recognition and management. Curr Infect Dis Rep 2004; 6:483-93. 3. Lucas S, Nelson AM. Pathogenesis of tuberculosis in human immunodeficiency virusinfected people. In: Bloom B, ed. Tuberculosis: pathogenesis, protection and control. Washington, DC: ASM Press, 1994:503-13. 4. Lucas S, Musallam R, Bain J, Hassounah O, Bickle Q, Doenhoff M. The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate. Trans R Soc Trop Med Hyg 1980; 74:633-43. 5. Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg 1997; 56:515-21. 6. Mwanakasale V, Vounatsou P, Sukwa T, Ziba M, Ernest A, Tanner M. Interaction between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia. Am J Trop Med Hyg 2003; 69:420-8. 7. Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications ofcoinfection for excretion of eggs. J Infect Dis 2005; 191:1311-20. 8. Brown M, Mawa P, Joseph S, et al. Treatment of Schistosoma mansoni increases helminthspecific type 2 cytokines and HIV-1 RNA concentrations in coinfected Ugandan adults. J Infect Dis 2005; 191:1648-57.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.